Scholarlink

Background <p>Sufentanil combined with esketamine for patient-controlled intravenous analgesia (PCIA) is an efficient options for postoperative pain control, which can result in a shortened hospital stay. However, no commercially formulated admixture of these two agents is currently available for clinical use. Furthermore, to date, no published data exist regarding the physicochemical stability of sufentanil and esketamine co-dissolved in 0.9% sodium chloride injection. The study aims to assess the stability of sufentanil and esketamine in infusion at both room temperature (25&#xa0;°C) and refrigerated conditions (4&#xa0;°C).</p> Methods <p>Commercial available injectable formulations of sufentanil and esketamine were were aseptically combined and diluted with 0.9% sodium chloride injection to yield final concentrations of 1.0&#xa0;µg/mL sufentanil and 0.25, 0.5, or 1.0&#xa0;mg/mL esketamine. The resulting admixtures were stored in polyvinyl chloride (PVC) infusion bags and assessed for compatibility and stability over 14 days at 4&#xa0;°C and over 48&#xa0;h at 25&#xa0;°C. Stability was evaluated through visual inspection (for precipitation or discoloration), pH measurement, and quantitative analysis of drug concentrations using validated liquid chromatography–tandem mass spectrometry (LC-MS/MS).</p> Results <p>All admixtures remained physically stable—no precipitation, turbidity, or color change was observed throughout the study period. The pH values varied by less than 0.80 units across all batches and time points under both storage conditions. Both sufentanil and esketamine retained ≥ 95% of their initial concentrations at all tested time points and temperatures.</p> Conclusion <p>Sufentanil (1.0&#xa0;µg/mL) combined with esketamine (0.25, 0.5, or 1.0&#xa0;mg/mL) in 0.9% sodium chloride injection demonstrated chemical and physical stability for up to 14 days under refrigerated storage and for up to 48&#xa0;h under room-temperature conditions when contained in PVC infusion bags.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Physicochemical stability of sufentanil and esketamine containing analgesic mixtures applied for patient-controlled intravenous analgesia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月14日

查看全文
  • Manman Yao,
  • Yuwen Ma,
  • Baoxia Fang,
  • Yun Du,
  • Yanhong Liu,
  • Fuchao Chen

摘要

Background

Sufentanil combined with esketamine for patient-controlled intravenous analgesia (PCIA) is an efficient options for postoperative pain control, which can result in a shortened hospital stay. However, no commercially formulated admixture of these two agents is currently available for clinical use. Furthermore, to date, no published data exist regarding the physicochemical stability of sufentanil and esketamine co-dissolved in 0.9% sodium chloride injection. The study aims to assess the stability of sufentanil and esketamine in infusion at both room temperature (25 °C) and refrigerated conditions (4 °C).

Methods

Commercial available injectable formulations of sufentanil and esketamine were were aseptically combined and diluted with 0.9% sodium chloride injection to yield final concentrations of 1.0 µg/mL sufentanil and 0.25, 0.5, or 1.0 mg/mL esketamine. The resulting admixtures were stored in polyvinyl chloride (PVC) infusion bags and assessed for compatibility and stability over 14 days at 4 °C and over 48 h at 25 °C. Stability was evaluated through visual inspection (for precipitation or discoloration), pH measurement, and quantitative analysis of drug concentrations using validated liquid chromatography–tandem mass spectrometry (LC-MS/MS).

Results

All admixtures remained physically stable—no precipitation, turbidity, or color change was observed throughout the study period. The pH values varied by less than 0.80 units across all batches and time points under both storage conditions. Both sufentanil and esketamine retained ≥ 95% of their initial concentrations at all tested time points and temperatures.

Conclusion

Sufentanil (1.0 µg/mL) combined with esketamine (0.25, 0.5, or 1.0 mg/mL) in 0.9% sodium chloride injection demonstrated chemical and physical stability for up to 14 days under refrigerated storage and for up to 48 h under room-temperature conditions when contained in PVC infusion bags.